LoginRegister
    Regeneron to invest 100 million dollar in bluebird, jointly develop cancer therapiesRegeneron to invest 100 million dollar in bluebird, jointly develop cancer therapies
    Novo Nordisk expects lower US prices next yearNovo Nordisk expects lower US prices next year
    Scandal-hit Chinese vaccine maker Changsheng started falsifying records in 2014: ReportScandal-hit Chinese vaccine maker Changsheng started falsifying records in 2014: Report
    Regulation of Oxytocin: Health Ministry holds video conference with States to discuss issuesRegulation of Oxytocin: Health Ministry holds video conference with States to discuss issues
    Sanofi launches multiple sclerosis drug in IndiaSanofi launches multiple sclerosis drug in India
    Alembic Pharma gets tentative USFDA approval for ophthalmic solutionAlembic Pharma gets tentative USFDA approval for ophthalmic solution
    Glenmark signs licence deal with Harbour BioMed to commercialise cancer antibody in Greater ChinaGlenmark signs licence deal with Harbour BioMed to commercialise cancer antibody in Greater China
    More problems found in Chinese-made heart medicationsMore problems found in Chinese-made heart medications
    Drug distributor Cardinals profit beats on pharma unit strengthDrug distributor Cardinal's profit beats on pharma unit strength
    After losing Fortis Bid, Manipal vyes to buy AMRI for upto Rs 1,000 croreAfter losing Fortis Bid, Manipal vyes to buy AMRI for upto Rs 1,000 crore
    Narcotics Bureau busts online pharmacy- Farma Glow for shipping illegal drugsNarcotics Bureau busts online pharmacy- Farma Glow for shipping illegal drugs
    Sun Pharma recalls over 5.2 thousand units of testosterone cypionate injections from USSun Pharma recalls over 5.2 thousand units of testosterone cypionate injections from US
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X